NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brett SandercockChief Financial Officer2026-01-021,000$241.75
$241.75kSell
Michael J. RiderGlobal General Counsel2026-01-0250$241.75
$12.09kSell
Michael J. FarrellChairman and CEO2025-12-084,991$146.34
$730.38kBuy
Michael J. FarrellChairman and CEO2025-12-084,991$251.41
$1.25MSell
Peter C. FarrellDirector2025-12-032,000$251.47
$502.94kSell
Michael J. RiderGlobal General Counsel2025-12-0150$244.16
$12.21kSell
Brett SandercockChief Financial Officer2025-12-011,000$244.16
$244.16kSell
Witte Jan DeDirector2025-11-252,055$255.00
$524.03kSell
Peter C. FarrellDirector2025-11-1411,442$101.64
$1.16MBuy
Peter C. FarrellDirector2025-11-147,314$244.46
$1.79MSell

1 of 9

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc13.04%19,040,440$4.74BInstitution
Blackrock Inc8.41%12,277,966$3.06BInstitution
State Street Corp4.49%6,549,164$1.63BInstitution
Bank Of New York Mellon Corp3.12%4,552,916$1.13BInstitution
Geode Capital Management LLC2.91%4,251,688$1.06BInstitution
Morgan Stanley1.58%2,313,138$576.41MInstitution
Invesco Ltd1.44%2,108,763$525.48MInstitution
Christopher G. Roberts1.16%1,700,337$423.71MInsider
Northern Trust Corp1.16%1,697,882$423.10MInstitution
Michael A. 1. Quinn0.88%1,277,650$318.38MInsider

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD62.63%4.27%Net SellingNet Selling
ALC48.18%0.00%
WST95.55%3.76%Net Buying
HOLX86.01%13.99%Net SellingNet Selling
COO98.84%1.16%Net SellingNet Buying

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 62.63% institutional shareholders, 4.27% Resmed insiders, and 33.10% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $422.04M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.